Esther Bouman‐Thio

Statistics

Publications

Citations

833

H-Index

Active since

2005

Affiliations

Janssen (United States)(Current)

Springhouse

Clinical and Laboratory Standards Institute

Janssen (Belgium)

Centre for Human Drug Research

Esther Bouman‐Thio is an author at Janssen (United States) specializing in pharmacokinetics, pharmacology, and pharmacokinetics of monoclonal antibodies.

Publications per year

2005–2016

Publications

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Honghui Zhou, Haishan Jang, Roy Fleischmann et al. · The Journal of Clinical Pharmacology · 2007 · 194 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Monoclonal antibody-induced cytokine-release syndrome

Peter J. Bugelski, Ram Achuthanandam, Renold J. Capocasale et al. · Expert Review of Clinical Immunology · 2009 · 162 citations

Pharmacy, Immunology, Pharmacology +17

Pharmacokinetics, pharmacodynamics and safety of a human anti‐IL‐6 monoclonal antibody (sirukumab) in healthy subjects in a first‐in‐human study

Zhenhua Xu, Esther Bouman‐Thio, Craig Comisar et al. · British Journal of Clinical Pharmacology · 2011 · 96 citations · Full text

Medicine, Immunology, Pharmacology +17

Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects

Zhenhua Xu, Qingmin Wang, Yanli Zhuang et al. · The Journal of Clinical Pharmacology · 2009 · 96 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis

Yanli Zhuang, César A. Calderón, Stanley J. Marciniak et al. · European Journal of Clinical Pharmacology · 2016 · 83 citations

Pharmacy, Immunology, Pharmacokinetics +13

1–5 of 13